EVE Health Group Limited
EVE Health Group Limited, together with its subsidiaries, engages in the development, retail, and commercialization of health and wellness, and pharmaceutical products. The company lead product is Dyspro, a proprietary pharmaceutical-grade formulation to address dysmenorrhea (menstrual pain); and Libbo, a proprietary pharmaceutical-grade oral dissolving film formulation for the treatment of erect… Read more
EVE Health Group Limited (EVE) - Net Assets
Latest net assets as of December 2025: AU$3.76 Million AUD
Based on the latest financial reports, EVE Health Group Limited (EVE) has net assets worth AU$3.76 Million AUD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$4.07 Million) and total liabilities (AU$307.63K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$3.76 Million |
| % of Total Assets | 92.44% |
| Annual Growth Rate | 13.44% |
| 5-Year Change | -65.13% |
| 10-Year Change | 102.84% |
| Growth Volatility | 182.71 |
EVE Health Group Limited - Net Assets Trend (2004–2025)
This chart illustrates how EVE Health Group Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for EVE Health Group Limited (2004–2025)
The table below shows the annual net assets of EVE Health Group Limited from 2004 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$3.55 Million | +190.24% |
| 2024-06-30 | AU$1.22 Million | -60.83% |
| 2023-06-30 | AU$3.12 Million | -54.93% |
| 2022-06-30 | AU$6.93 Million | -31.95% |
| 2021-06-30 | AU$10.19 Million | -21.59% |
| 2020-06-30 | AU$12.99 Million | +122.15% |
| 2019-06-30 | AU$5.85 Million | -20.75% |
| 2018-06-30 | AU$7.38 Million | +165.71% |
| 2017-06-30 | AU$2.78 Million | +58.60% |
| 2016-06-30 | AU$1.75 Million | -33.76% |
| 2015-06-30 | AU$2.64 Million | -67.38% |
| 2014-06-30 | AU$8.11 Million | -0.89% |
| 2013-06-30 | AU$8.18 Million | -64.50% |
| 2012-06-30 | AU$23.04 Million | -10.15% |
| 2011-06-30 | AU$25.64 Million | +1.95% |
| 2010-06-30 | AU$25.15 Million | +9.66% |
| 2009-06-30 | AU$22.93 Million | -10.55% |
| 2008-06-30 | AU$25.64 Million | +36.51% |
| 2007-06-30 | AU$18.78 Million | +214.10% |
| 2006-06-30 | AU$5.98 Million | +169.17% |
| 2005-06-30 | AU$2.22 Million | +783.85% |
| 2004-06-30 | AU$251.35K | -- |
Equity Component Analysis
This analysis shows how different components contribute to EVE Health Group Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3609759800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$39.74 Million | 1118.72% |
| Other Comprehensive Income | AU$-2.50 Million | -70.49% |
| Other Components | AU$2.50 Million | 70.49% |
| Total Equity | AU$3.55 Million | 100.00% |
EVE Health Group Limited Competitors by Market Cap
The table below lists competitors of EVE Health Group Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Usha Resources Ltd
OTCMKTS:USHAF
|
$1.78 Million |
|
Sanwaria Consumer Limited
NSE:SANWARIA
|
$1.78 Million |
|
Coppermoly Limited
F:5C5
|
$1.78 Million |
|
UNIV HEALTH SERV-B
BE:UHS
|
$1.78 Million |
|
Millennium Group International Holdings Limited Ordinary Shares
NASDAQ:MGIH
|
$1.78 Million |
|
Afyren SAS
PA:ALAFY
|
$1.78 Million |
|
Kafrit
TA:KAFR
|
$1.78 Million |
|
Till Capital Ltd
PINK:TILCF
|
$1.78 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in EVE Health Group Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,223,992 to 3,552,522, a change of 2,328,530 (190.2%).
- Net loss of 1,579,955 reduced equity.
- Share repurchases of 124,013 reduced equity.
- New share issuances of 1,032,500 increased equity.
- Other comprehensive income decreased equity by 2,698,192.
- Other factors increased equity by 5,698,190.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-1.58 Million | -44.47% |
| Share Repurchases | AU$124.01K | -3.49% |
| Share Issuances | AU$1.03 Million | +29.06% |
| Other Comprehensive Income | AU$-2.70 Million | -75.95% |
| Other Changes | AU$5.70 Million | +160.4% |
| Total Change | AU$- | 190.24% |
Book Value vs Market Value Analysis
This analysis compares EVE Health Group Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.77x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 4.53x to 0.77x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-06-30 | AU$0.00 | AU$0.02 | x |
| 2005-06-30 | AU$0.02 | AU$0.02 | x |
| 2006-06-30 | AU$0.03 | AU$0.02 | x |
| 2007-06-30 | AU$0.05 | AU$0.02 | x |
| 2008-06-30 | AU$0.05 | AU$0.02 | x |
| 2009-06-30 | AU$0.05 | AU$0.02 | x |
| 2010-06-30 | AU$0.04 | AU$0.02 | x |
| 2011-06-30 | AU$0.05 | AU$0.02 | x |
| 2012-06-30 | AU$0.05 | AU$0.02 | x |
| 2013-06-30 | AU$0.02 | AU$0.02 | x |
| 2014-06-30 | AU$0.01 | AU$0.02 | x |
| 2015-06-30 | AU$0.01 | AU$0.02 | x |
| 2016-06-30 | AU$0.00 | AU$0.02 | x |
| 2017-06-30 | AU$0.00 | AU$0.02 | x |
| 2018-06-30 | AU$0.00 | AU$0.02 | x |
| 2019-06-30 | AU$0.00 | AU$0.02 | x |
| 2020-06-30 | AU$0.00 | AU$0.02 | x |
| 2021-06-30 | AU$0.00 | AU$0.02 | x |
| 2022-06-30 | AU$0.00 | AU$0.02 | x |
| 2023-06-30 | AU$0.00 | AU$0.02 | x |
| 2024-06-30 | AU$0.00 | AU$0.02 | x |
| 2025-06-30 | AU$0.03 | AU$0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently EVE Health Group Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -44.47%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -91.08%
- • Asset Turnover: 0.42x
- • Equity Multiplier: 1.16x
- Recent ROE (-44.47%) is above the historical average (-55.21%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | -36.89% | 0.00% | 0.00x | 1.57x | AU$-117.85K |
| 2005 | -6.01% | -417.58% | 0.01x | 1.12x | AU$-355.78K |
| 2006 | -4.11% | -201.64% | 0.02x | 1.05x | AU$-843.97K |
| 2007 | -17.37% | -602.04% | 0.02x | 1.27x | AU$-4.18 Million |
| 2008 | -18.25% | -943.71% | 0.01x | 1.63x | AU$-4.65 Million |
| 2009 | -24.14% | 0.00% | 0.00x | 1.56x | AU$-5.09 Million |
| 2010 | -27.72% | -628.39% | 0.02x | 2.16x | AU$-4.61 Million |
| 2011 | 82.77% | 277.36% | 0.29x | 1.04x | AU$18.66 Million |
| 2012 | -22.57% | 0.00% | 0.00x | 1.03x | AU$-7.50 Million |
| 2013 | -212.56% | -255571.89% | 0.00x | 1.01x | AU$-18.20 Million |
| 2014 | -4.77% | -13719.83% | 0.00x | 1.01x | AU$-1.20 Million |
| 2015 | -278.66% | -3721212.12% | 0.00x | 1.05x | AU$-7.63 Million |
| 2016 | -63.04% | 0.00% | 0.00x | 1.10x | AU$-1.28 Million |
| 2017 | -49.95% | -554941.20% | 0.00x | 1.11x | AU$-1.67 Million |
| 2018 | -25.47% | -9944.99% | 0.00x | 1.01x | AU$-2.62 Million |
| 2019 | -45.12% | -165.14% | 0.18x | 1.50x | AU$-3.22 Million |
| 2020 | -18.47% | -103.85% | 0.16x | 1.09x | AU$-3.70 Million |
| 2021 | -35.64% | -129.63% | 0.23x | 1.17x | AU$-4.65 Million |
| 2022 | -77.48% | -267.40% | 0.25x | 1.16x | AU$-6.07 Million |
| 2023 | -129.41% | -173.49% | 0.56x | 1.32x | AU$-4.36 Million |
| 2024 | -155.31% | -89.08% | 0.85x | 2.06x | AU$-2.02 Million |
| 2025 | -44.47% | -91.08% | 0.42x | 1.16x | AU$-1.94 Million |
Industry Comparison
This section compares EVE Health Group Limited's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $123,390,853
- Average return on equity (ROE) among peers: -43.64%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| EVE Health Group Limited (EVE) | AU$3.76 Million | -36.89% | 0.08x | $1.78 Million |
| Australian Dairy Nutritionals Ltd (AHF) | $953.22K | -6.33% | 0.59x | $7.89 Million |
| Beston Global Food Company Ltd (BFC) | $113.64 Million | -1.66% | 0.03x | $3.27 Million |
| Biome Australia Ltd (BIO) | $6.53 Million | -69.59% | 0.26x | $31.40 Million |
| Bioxyne Ltd (BXN) | $1.55 Million | 14.43% | 0.30x | $21.29 Million |
| Cobram Estate Olives Ltd (CBO) | $179.76 Million | 4.87% | 1.29x | $623.31 Million |
| The Calmer Co International Ltd (CCO) | $1.90 Million | -209.79% | 1.98x | $2.07 Million |
| Forbidden Foods Ltd (FFF) | $3.06 Million | -113.04% | 0.42x | $1.49 Million |
| Fonterra Shareholders Fund (FSF) | $763.00 Million | 4.85% | 0.00x | $26.81K |
| Health and Plant Protein Group Ltd (HPP) | $40.13 Million | -16.51% | 1.31x | $448.86K |